Biomarkers for Oncology
JH · Effective Oct 1, 2015
69 active Medicare policies list 81445, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81445 |
|---|---|---|
| Genetic Testing for Hematologic Malignancies and Suspected Myeloid Disorders | Sep 1, 2026 | Covered |
| Genetic Testing for Hereditary Colorectal and Uterine Cancer | Apr 1, 2026 | Covered |
| Policy | Effective | Status of 81445 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J5 · Effective Mar 15, 2020
J8 · Effective Mar 15, 2020
J15 · Effective Jul 18, 2021
JE · Effective Jul 25, 2021
JF · Effective Jul 25, 2021
JJ · Effective Jul 18, 2021
JM · Effective Jul 18, 2021
J5 · Effective Jul 18, 2021
J8 · Effective Jul 18, 2021
J9 · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
J6 · Effective Feb 26, 2026
National · Effective Mar 12, 2026
National · Effective Mar 12, 2026
National · Effective Mar 12, 2026
J5 · Effective Mar 12, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Feb 5, 2026
J5 · Effective Apr 1, 2026
National · Effective Apr 1, 2025
J5 · Effective Apr 1, 2025
National · Effective Apr 1, 2025
National · Effective Feb 5, 2026
National · Effective Jul 1, 2025
National · Effective May 1, 2025
J5 · Effective Jul 1, 2025
National · Effective Feb 5, 2026
National · Effective Jan 1, 2024
National · Effective Jan 1, 2024
National · Effective Feb 5, 2026
J5 · Effective Jan 1, 2024
JL · Effective Apr 1, 2026
J9 · Effective Apr 1, 2026
| Policy | Effective | Status of 81445 |
|---|---|---|
| Concert Genetic Testing Oncology: Solid Tumor Molecular Diagnostics | Not recorded | Referenced |
| Policy | Effective | Status of 81445 |
|---|---|---|
| Cigna Comprehensive Code List - Effective 03/07/2026 | Mar 7, 2026 | Prior auth required |
| Policy | Effective | Status of 81445 |
|---|---|---|
| Expanded Molecular Testing of Cancers to Select Targeted Therapies | Jul 1, 2026 | Covered |